Lista de obras - Anita Dunbier - Dominio Público Uruguay

A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse.

artículo científico publicado en 2016

A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance

artículo científico publicado en 2011

A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population

artículo científico publicado en 2008

Abstract 4518: 4CSeq analysis of a breast cancer susceptibility locus on 6q25.1

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer

artículo científico publicado en 2015

Association between breast cancer subtypes and response to neoadjuvant anastrozole

artículo científico publicado en 2011

Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor-Treated ER-Positive Breast Cancer

artículo científico publicado en 2011

Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

artículo científico publicado en 2013

Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer

scientific article published on 01 March 2007

Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer

artículo científico publicado en 2014

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer

artículo científico publicado en 2011

ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1

artículo científico publicado en 2011

Effect of aromatase inhibition on functional gene modules in estrogen receptor-positive breast cancer and their relationship with antiproliferative response

artículo científico publicado en 2014

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

scientific article published on December 2008

Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer

artículo científico publicado en 2011

Exploring breast cancer estrogen disposition: the basis for endocrine manipulation

artículo científico publicado en 2011

Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers

Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition

artículo científico publicado en 2008

Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.

artículo científico publicado en 2014

Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo

artículo científico publicado en 2008

Increased gene expression variability in BRCA1-associated and basal-like breast tumours

artículo científico publicado en 2021

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer

artículo científico publicado en 2015

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

article

Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance

scientific article published on 14 March 2013

N-terminal E-cadherin peptides act as decoy receptors for Listeria monocytogenes.

artículo científico publicado en 2003

New and translational perspectives of oestrogen deprivation in breast cancer

artículo científico publicado en 2011

Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer

artículo científico publicado en 2021

Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.

artículo científico publicado en 2012

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

artículo científico publicado en 2013

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study

artículo científico publicado en 2010

Progress in aromatase research and identification of key future directions

artículo científico publicado en 2009

Recent data on intratumor estrogens in breast cancer

artículo científico publicado en 2011

Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women

artículo científico publicado en 2010

Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1

artículo científico publicado en 2018

Variable expression quantitative trait loci analysis of breast cancer risk variants

artículo científico publicado en 2021

Lista de obras de Anita Dunbier

A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse.

A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance

A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population

Abstract 4518: 4CSeq analysis of a breast cancer susceptibility locus on 6q25.1

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer

Association between breast cancer subtypes and response to neoadjuvant anastrozole

Close and Stable Relationship between Proliferation and a Hypoxia Metagene in Aromatase Inhibitor-Treated ER-Positive Breast Cancer

Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer

Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer

ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1

Effect of aromatase inhibition on functional gene modules in estrogen receptor-positive breast cancer and their relationship with antiproliferative response

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer

Exploring breast cancer estrogen disposition: the basis for endocrine manipulation

Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers

Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition

Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.

Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo

Increased gene expression variability in BRCA1-associated and basal-like breast tumours

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance

N-terminal E-cadherin peptides act as decoy receptors for Listeria monocytogenes.

New and translational perspectives of oestrogen deprivation in breast cancer

Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer

Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study

Progress in aromatase research and identification of key future directions

Recent data on intratumor estrogens in breast cancer

Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women

Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1

Variable expression quantitative trait loci analysis of breast cancer risk variants